DSCSA Provisions Delayed until November 2024
In July 2023, several pharmacy organizations (NABP, APhA, NACDS) sent a joint letter to the Food and Drug Administration (FDA). The letter asked the FDA to use its authority to delay the final implementation deadline for the Drug Supply Chain Security Act (DSCSA) until February 2026. The FDA responded to this request with an announcement on 8/25/23 that the effective date for full implementation of the DSCSA will be delayed for one year, becoming effective and enforceable on 11/27/24.
Read More
Is butalbital a controlled substance? It’s complicated…
The New Year is upon us and 2023 has already delivered some regulatory news that’s worth sharing.
Read More
Understanding Biosimilars
Summary: This article explores the imminent release of a feature within FrameworkLTC aiding pharmacies in making informed decisions on biosimilar substitutions, accompanied by an overview of biologic drugs, their classifications, and the regulatory landscape surrounding their substitution. Table of Contents
Read More
How Did We Get Here? The History of Pharmacy Automation Systems
Summary: This article highlights the evolution and current impact of pharmacy automation systems.
Read More